Across 700 million years of natural selection, venomous lineages evolved over 20 million surgical toxin peptides. Scroll down to zoom from evolutionary radiation into our 6-stage AI discovery engine.
Ethical micro-sampling across India’s extraordinary venom biodiversity and global collections accesses >20M evolutionarily honed peptides across 700 million years of natural selection.
Millions of venom-derived peptides, evolved for potency and selectivity across biological targets.
Searching nature’s molecular diversity across many disease-relevant targets
Hundreds of millions of years of evolution. Built into every molecule.
Anchored in India’s extraordinary venom biodiversity and deep toxinology expertise.
Venom-derived medicines already exist.
Explore the molecule behind each discovery.
Bothrops jararaca
Small-molecule ACE inhibitor
Inspired by venom peptides.
The molecule shown is captopril, the medicine developed from that insight.
Hover or tap to reveal the molecule ↗
Conus magus
Prialt
A synthetic equivalent of ω-conotoxin MVIIA.
Explore the folded 25-residue peptide.
Hover or tap to reveal the molecule ↗
Heloderma suspectum
Byetta
Based on exendin-4 from Gila monster saliva.
Explore an experimentally determined peptide conformation.
Hover or tap to reveal the molecule ↗
Venomics AI is building a scalable discovery engine that transforms the intelligence encoded in venoms into new medicines.
Six high-impact programs where evolutionary toxin scaffolds unlock targets undruggable by conventional small molecules or biologics.
Selective subtype modulators of voltage-gated sodium (NaV1.7, NaV1.8) and calcium channels for severe chronic pain without opioid addiction.
TARGET // NaV1.7 · TRPV1 · CaV2.2Next-generation incretin and metabolic GPCR agonists building on the Gila monster exendin-4 precedent for durable weight loss and glycemic control.
TARGET // GLP-1R · GIPR · GCGR500,000+ cataloged antimicrobial peptides engineered to disrupt multidrug-resistant Gram-negative pathogens with minimal mammalian toxicity.
TARGET // ESKAPE PATHOGENSVenom-derived chlorotoxin and knottin scaffolds engineered as tumor-penetrating radioligand and cytotoxic conjugates.
TARGET // MMP-2 · CLCN3 · MCL-1Selective senolytic and senomorphic venom peptides targeting pathological senescent cells in fibrosis and age-related degeneration.
TARGET // SENESCENT SECRETOMEBiodegradable, pollinator-safe insecticidal knottins that selectively paralyze crop pests and disease vectors without environmental persistence.
TARGET // INSECT NaV / nAChRA multidisciplinary team spanning toxinology, computational biology, and machine learning.
KS
An evolutionary biologist at the Indian Institute of Science, Bengaluru, Prof. Sunagar has built one of India’s leading venom research programs. His work spans venom evolution, snakebite therapeutics, antibody discovery, small-molecule inhibitors, and the translational use of venom biology for medicine.
VP
Dr. Prabhu brings deep expertise in machine learning, large-scale AI systems, and computational biology. At Venomics AI, he leads the development of AI platforms that convert venom datasets into therapeutic insights and drug discovery programs.
Our platform builds on years of peer-reviewed research in venom biology, toxin pharmacology, and snakebite therapeutics.
Stories from Prof. Kartik Sunagar on venom biology, snakebite, evolution, and the adventures that connect them.
Key milestones, funding announcements, and press features from the Venomics AI team.
Venomics AI has been accepted into NVIDIA Inception, a program supporting startups advancing technology through AI and accelerated computing.
Accelerating our work at the intersection of venom biology and AI.
Venomics AI has been selected among the Top 5 companies for the 2026 Indo-Boston Biotech Bridge Award.
Recognized by Nucleate India and ABLE, powered by LabCentral.
Venomics AI raised $2.7M USD in pre-seed funding to establish its integrated venom-to-therapeutics discovery platform.
Capital to build the discovery platform · Covered across 18 media outlets.
Kartik Sunagar’s Evolutionary Venomics Lab at IISc has been awarded Anthropic AI for Science Grant to use Claude to annotate venom data and find shared targets for next-generation antivenoms.
Addressing a nationwide problem that kills an estimated 58,000 people a year.
Whether you're an investor, scientist, or patient advocate, we want to hear from you.
Partnerships, licensing, investor conversations, media, and scientific collaborations.
No 33, 4th Floor, 1st Main, Ganganagar Gramatana, HMT, R T Nagar, Bengaluru 560032, Karnataka, India
Incorporated in Delaware, USA, on 8 October 2026 as a wholly owned subsidiary
Thank you for contacting us. We'll get back to you soon.
Something went wrong. Please try again or email us directly.
